当前位置: X-MOL首页SCI期刊查询及投稿分析系统 › Blood Cancer Journal杂志
Blood Cancer Journal
基本信息
期刊名称 Blood Cancer Journal
BLOOD CANCER J
期刊ISSN 2044-5385
期刊官方网站 http://www.nature.com/bcj/index.html
是否OA
出版商 Nature Publishing Group
出版周期
文章处理费 登录后查看
始发年份 2011
年文章数 69
影响因子 12.9(2023)  scijournal影响因子  greensci影响因子
中科院SCI期刊分区
大类学科 小类学科 Top 综述
医学1区 HEMATOLOGY 血液学2区
ONCOLOGY 肿瘤学2区
CiteScore
CiteScore排名 CiteScore SJR SNIP
学科 排名 百分位 3.85 2.820 1.658
Medicine
Hematology
13 / 122 89%
Medicine
Oncology
63 / 321 80%
补充信息
自引率 5.30%
H-index 26
SCI收录状况 Science Citation Index Expanded
官方审稿时间 登录后查看
网友分享审稿时间 数据统计中,敬请期待。
接受率 登录后查看
PubMed Central (PMC) http://www.ncbi.nlm.nih.gov/nlmcatalog?term=2044-5385%5BISSN%5D
投稿指南
期刊投稿网址 http://mts-bcj.nature.com/cgi-bin/main.plex
收稿范围

Blood Cancer Journal 力图发表与血液恶性肿瘤和相关疾病的高质量文章。 

期刊收录研究方向:新化合物的临床前研究,临床实验和观察,有关新药和当前血液恶性肿瘤的综述,与新突变、分子途径和肿瘤基因组学相关的新发现,等

收录体裁
Articles
Review Article
Correspondence
Current Treatment Algorithms
Editorials (by Editor invitation only)
Meeting Reports
投稿指南 https://www.nature.com/documents/bcj-gta.pdf
投稿模板
参考文献格式 https://www.nature.com/documents/bcj_gta.pdf
编辑信息

Editors-in-Chief

Dr Ayalew Tefferi

Dr Ayalew Tefferi was born in Addis Ababa, Ethiopia, and migrated to the United States in 1982 after completing his medical school education at the University of Athens in Athens, Greece. Dr Tefferi received his Hematology training at the Mayo Clinic in Rochester MN before joining the staff at the Mayo Clinic College of Medicine, Division of Hematology in the Department of Medicine. He has been a full professor in Hematology and Internal Medicine since 2001.

Dr Tefferi is primarily engaged in direct patient care and sees patients every afternoon. His clinical and laboratory interests focus on myeloid disorders including polycythemia vera, essential thrombocythemia, myelofibrosis, chronic myeloid leukemia, myelodysplastic syndromes, acute leukemia, eosinophilic disorders and systemic mastocytosis. He also serves as division resource for anemia, porphyria, hemochromatosis and hemoglobinopathies.

Dr Tefferi's academic and research achievements include over 1000 publications including books, book chapters, original articles, reviews, editorials, letters, and abstracts. Dr Tefferi serves as associate or section editor for the Mayo Clinic Proceedings, Leukemia, American Journal of Hematology, European Journal of Hematology, and Hematological Oncology. He is also in the editorial board of several other journals including Journal of Clinical Oncology, Blood, Cancer, Leukemia Research, Acta Haematologica, and Leukemia and Lymphoma. Dr Tefferi has given more than 700 national and international invited lectureships and serves as faculty for the annual Hematology and Oncology Board review courses at George Washington University in Washington DC, Cancer Medicine and Hematology offered by Harvard institutes in Boston MA, and MD Anderson Cancer Center in Houston TX.

S. Vincent Rajkumar, MD

Dr Rajkumar is Professor of Medicine at the Mayo Clinic, Rochester, Minnesota, and Chair of the Mayo Clinic Myeloma, Amyloidosis, and Dysproteinemia Group. He is also the Chair of the Eastern Cooperative Oncology Group (ECOG) Myeloma Committee. Dr Rajkumar has a multi-faceted research program involving clinical trials, epidemiologic studies, and laboratory research. He has led several clinical trials investigating the role of new agents in myeloma, including the pivotal trials that led to the approval of thalidomide in myeloma in the United States. As chair of the ECOG myeloma committee he leads the design and implementation of several national phase III randomized trials for the disease. Dr Rajkumar also leads several large epidemiologic studies investigating the prevalence and progression of various monoclonal gammopathies. The research is primarily funded by the National Institutes of Health, USA. His current laboratory research is focused on investigating novel agents in myeloma, and studying the role of angiogenesis in various plasma cell disorders. He has published more than 230 peer-reviewed papers primarily in the field of myeloma and related plasma cell disorders. In addition to his editorial role in the Blood Cancer Journal, Dr Rajkumar currently serves as the Section Editor for multiple myeloma and related disorders for Leukemia and as an Associate Editor for the Mayo Clinic Proceedings.

Associate Editors

Omar Abdel-Wahab, Memorial-Sloan Kettering Cancer Center, USA
Stephen Ansell, Mayo Clinic, USA
Naseema Gangat, Mayo Clinic, USA
Andreas Hochhaus, University Medical Center Jena, Germany
Sagar Lonial, Winship Cancer Institute, Emory University, USA
Mohamad Mohty, CHU de Nantes, France
Eric Solary, Institut de Cancérologie Gustave, Roussy, France
Alessandro Vannucchi, University of Florence, Italy

我要分享  (欢迎您来完善期刊的资料,分享您的实际投稿经验)
研究领域:
投稿录用情况: 审稿时间:  个月返回审稿结果
本次投稿点评:
提交
down
wechat
bug